GOCM
ELDN icon

Green Owl Capital Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Green Owl Capital Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-818
Closed -$1.16M – 60
2015
Q4 		$1.16M Sell
818
-46
-5% -$80.1K 1.36% 28
2015
Q3 		$1.45M Buy
864
+62
+8% +$128K 1.12% 29
2015
Q2 		$1.73M Buy
802
+123
+18% +$238K 1.23% 24
2015
Q1 		$1.24M Buy
679
+148
+28% +$327K 0.94% 33
2014
Q4 		$1.27M Buy
+531
New +$1.26M 1.14% 30

Other funds holding ELDN

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Green Owl Capital Management's ELDN Position: Q1 2016 in Review

Green Owl Capital Management sold out of Eledon Pharmaceuticals (ELDN) in Q1 2016, closing a stake of 818 shares — an estimated $1.16M sold.

Green Owl Capital Management first reported a position in ELDN in Q4 2014 and held it in 5 quarters. The position peaked at $1.73M in Q2 2015. 49 funds tracked by Wall St. Rank hold ELDN as of Q1 2016.

  • Green Owl Capital Management reported no remaining Eledon Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Green Owl Capital Management sold 818 Eledon Pharmaceuticals shares in Q1 2016, an estimated $1.16M.
  • Green Owl Capital Management first reported a position in Eledon Pharmaceuticals in Q4 2014 and held it in 5 quarters.
  • Green Owl Capital Management's Eledon Pharmaceuticals position peaked at $1.73M in Q2 2015.
  • 49 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2016.

Based on Green Owl Capital Management's 13F filing for Q1 2016, filed 12 May 2016.